Blood Culture Tests Market worth 4,768.9 Million USD by 2021


Posted July 24, 2018 by snehalshaha

The global blood culture tests market is projected to reach USD 4,768.9 Million by 2021 from USD 3,252.6 Million in 2016, at a CAGR of 8.0%.

 
The report "Blood Culture Tests Market by Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia) & End User (Hopsital Laboratories, Reference Laboratories) - Global Forecast to 2021", The global blood culture tests market is projected to reach USD 4,768.9 Million by 2021 from USD 3,252.6 Million in 2016, at a CAGR of 8.0%. Factors such as rapidly rising aging population, increase in product approvals and launches, high incidence of bloodstream infections, high prevelance of infectious diseases, and increase in demand for rapid diagnostic techniques are driving the growth of the blood culture tests market during the forecast period.

Browse 300 market data Tables and 50 Figures spread through 249 Pages and in-depth TOC on "Blood Culture Tests Market by Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia) & End User (Hopsital Laboratories, Reference Laboratories) - Global Forecast to 2021"
http://www.marketsandmarkets.com/Market-Reports/blood-culture-test-market-159606753.html
Early buyers will receive 10% customization on reports.
In this report, the blood culture tests market is segmented on the basis of method, product, technology, application, end user, and region. Based on end user, the blood culture tests market is segmented into hospital laboratories, reference laboratories, academic research laboratories, and other laboratories (pathology laboratories, bacteriological laboratories, physician office laboratories (POLs), and independent research laboratories). The reference laboratories segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing outsourcing of blood culture tests by hospitals to reference laboratories, as they can perform a large volume of tests and are equipped with advanced diagnostic techniques that provide blood culture tests with a quick turnaround time.
Geographically, the blood culture tests market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the blood culture tests market. However, the Asian market is expected to grow at the highest CAGR. Growth in the Asian market can be attributed to the high incidence of sepsis and government initiatives to increase awareness on the disease, increasing demand for effective diagnostic techniques, rising awareness about early disease diagnosis, increasing adoption of advanced technologies, rapid rise in geriatric population, and growing regulatory approvals & availability of blood culture test products in this region.
The blood culture tests market is highly competitive, with prominent players such as Becton, Dickinson and Company (U.S.), bioMérieux SA (France), and Thermo Fisher Scientific, Inc. (U.S.). Some of the other players in this market include Cepheid, Inc. (U.S.), Nanosphere, Inc. (U.S.), IRIDICA (U.S.), Beckman Coulter (U.S.), Bruker Corporation (U.S.), and T2 Biosystems (U.S.).
About MarketsandMarkets
MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Shelly
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By digitalmarket
Phone 1-888-600-6441
Business Address Markets and Markets ,UNIT no 802, Tower no. 7, SEZ,Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Country United States
Categories Biotech , Health , Medical
Tags blood culture tests market
Last Updated July 24, 2018